The Racing Medication and Testing Consortium, a group of 23 major horseracing industry stakeholders, was created after a December 2001 racehorse medication summit in Tucson, Ariz.
The RMTC, with offices in Lexington, Ky., is responsible for authorizing research related to equine medication and testing and develops model rules based on broad industry consensus. Its mission statement says the organization strives “to develop and promote uniform rules, policies and testing standards at the national level; coordinate research and educational programs that seek to ensure the integrity of racing and the health and welfare of racehorses and participants; and protect the interests of the betting public.”
The RMTC is largely responsible for creation of the National Uniform Medication Program, which has its roots in the Mid-Atlantic region. The RMTC advocates for the program on a state-by-state basis and regularly tracks adoption of the program’s four major proponents: the Controlled Therapeutic Medication Schedule, third-party administration of race-day Lasix, laboratory accreditation, and the multiple medication violation penalty system.
More information on the Racing Medication and Testing Consortium is available here